Genetic ablation of solute carrier family 7a3a leads to hepatic steatosis in zebrafish during fasting

Hepatology

Volumn 60, Issue 6, 2014, Pages 1929-1941

  Gu, Qilin ^a,b   Yang, Xiaojie ^a,b   Lin, Li ^c   Li, Shaoyang ^c   Li, Qing ^a   Zhong, Shan ^c   Peng, Jinrong ^d   Cui, Zongbin ^a  

^a INSTITUTE OF HYDROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c WUHAN UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORTER; CYCLIC GMP; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR-1ALPHA, ZEBRAFISH; SLC7A3A PROTEIN, HUMAN; TRANSCRIPTION FACTOR; ZEBRAFISH PROTEIN;

ANIMAL; CELL LINE; COMPLICATION; DIET RESTRICTION; FATTY LIVER; HUMAN; LIPID METABOLISM; LIVER; METABOLISM; MOUSE; MUTATION; PHENOTYPE; PHYSIOLOGY; STARVATION; ZEBRA FISH;

AMINO ACID TRANSPORT SYSTEMS, BASIC; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CELL LINE; CYCLIC GMP; FASTING; FATTY LIVER; HUMANS; LIPID METABOLISM; LIVER; MICE; MUTATION; NITRIC OXIDE; PHENOTYPE; PPAR ALPHA; STARVATION; TRANSCRIPTION FACTORS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84911892700     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27356     Document Type: Article

References (32)

1. Closs EI, Boissel JP, Habermeier A, Rotmann A. Structure and function of cationic amino acid transporters (CATs). J Membr Biol 2006;213:67-77.
2. Perkins CP, Mar V, Shutter JR, del Castillo J, Danilenko DM, Medlock ES, et al. Anemia and perinatal death result from loss of the murine ecotropic retrovirus receptor mCAT-1. Genes Dev 1997;11:914-925.
3. Nicholson B, Manner CK, Kleeman J, MacLeod CL. Sustained nitric oxide production in macrophages requires the arginine transporter CAT2. J Biol Chem 2001;276:15881-15885.
4. Gu Q, Yang X, He X, Li Q, Cui Z. Generation and characterization of a transgenic zebrafish expressing the reverse tetracycline transactivator. J Genet Genomics 2013;40:523-531.
5. Luiking YC, Engelen MP, Deutz NE. Regulation of nitric oxide production in health and disease. Curr Opin Clin Nutr Metab Care 2010;13:97-104.
6. Nisoli E, Falcone S, Tonello C, Cozzi V, Palomba L, Fiorani M, et al. Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals. Proc Natl Acad Sci U S A 2004;101:16507-16512.
7. Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, Tedesco L, et al. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 2005;310:314-317.
8. Lira VA, Brown DL, Lira AK, Kavazis AN, Soltow QA, Zeanah EH, Criswell DS. Nitric oxide and AMPK cooperatively regulate PGC-1α in skeletal muscle cells. J Physiol 2010;588:3551-3566.
9. Jäger S, Handschin C, St-Pierre J, Spiegelman BM. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc Natl Acad Sci U S A 2007;104:12017-12022.
10. Kroetz DL, Yook P, Costet P, Bianchi P, Pineau T. Peroxisome proliferator-activated receptor alpha controls the hepatic CYP4A induction adaptive response to starvation and diabetes. J Biol Chem 1998;273:31581-31589.
11. Kersten S, Seydoux J, Peters JM, Gonzalez FJ, Desvergne B, Wahli W. Peroxisome proliferator-activated receptor α mediates the adaptive response to fasting. J Clin Invest 1999;103:1489-1498.
12. Ventura-Clapier R, Garnier A, Veksler V. Transcriptional control of mitochondrial biogenesis: the central role of PGC-1α. Cardiovas Res 2008;79:208-217.
13. Zhang YL, Guo H, Zhang CS, Lin SY, Yin Z, Peng Y, et al. AMP as a low-energy charge signal autonomously initiates assembly of AXIN-AMPK-LKB1 complex for AMPK activation. Cell Metab 2013;18:546-555.
14. Korotchkina LG, Leontieva OV, Bukreeva EI, Demidenko ZN, Gudkov AV, Blagosklonny MV. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway. Aging (Albany NY) 2010;2:344.
15. Vazquez-Chantada M, Gonzalez-Lahera A, Martinez-Arranz I, Garcia-Monzon C, Regueiro MM, Garcia-Rodriguez JL, et al. Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease. Hepatology 2013;57:505-514.
16. Hugo SE, Cruz-Garcia L, Karanth S, Anderson RM, Stainier DY, Schlegel A. A monocarboxylate transporter required for hepatocyte secretion of ketone bodies during fasting. Genes Dev 2012;26:282-293.
17. Mo S, Wang L, Li Q, Li J, Li Y, Thannickal VJ, Cui Z. Caveolin-1 regulates dorsoventral patterning through direct interaction with β-catenin in zebrafish. Dev Biol 2010;344:210-223.
18. Lepiller S, Laurens V, Bouchot A, Herbomel P, Solary E, Chluba J. Imaging of nitric oxide in a living vertebrate using a diaminofluorescein probe. Free Radical Bio Med 2007;43:619-627.
19. Leite CE, Teixeira Ada C, Cruz FF, Concatto SC, Amaral JH, Bonan CD, et al. Analytical method for determination of nitric oxide in zebrafish larvae: toxicological and pharmacological applications. Anal Biochem 2012;421:534-540.
20. Francis SH, Busch JL, Corbin JD, Sibley D. cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. Pharmacol Rev 2010;62:525-563.
21. Rautou PE, Cazals-Hatem D, Moreau R, Francoz C, Feldmann G, Lebrec D, et al. Acute liver cell damage in patients with anorexia nervosa: a possible role of starvation-induced hepatocyte autophagy. Gastroenterology 2008;135:840-848, 848.e1-3.
22. van Ginneken V, Verhey E, Poelmann R, Ramakers R, van Dijk KW, Ham L, et al. Metabolomics (liver and blood profiling) in a mouse model in response to fasting: a study of hepatic steatosis. Biochim Biophys Acta 2007;1771:1263-1270.
23. Postic C, Girard J. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J Clin Invest 2008;118:829-838.
24. Reif S, Lu RB, Tano M, Terranova V, Young C, Fisher J, et al. Perinatal food restriction in rats reduces the content but not concentration of liver extracellular matrix proteins. J Nutr 1993;123:811-816.
25. Yasuhara M, Ohama T, Matsuki N, Saito H, Shiga J, Inoue K, et al. Induction of fatty liver by fasting in suncus. J Lipid Res 1991;32:887-891.
26. Gibbons GF, Burnham FJ. Effect of nutritional state on the utilization of fatty acids for hepatitic triacylglycerol synthesis and secretion as very-low-density lipoprotein. Biochem J 1991;275:87-92.
27. van der Velden YU, Wang L, Zevenhoven J, van Rooijen E, van Lohuizen M, Giles RH, et al. The serine-threonine kinase LKB1 is essential for survival under energetic stress in zebrafish. Proc Natl Acad Sci U S A 2011;108:4358-4363.
28. Fryer L, Hajduch E, Rencurel F, Salt IP, Hundal HS, Hardie DG, Carling D. Activation of glucose transport by AMP-activated protein kinase via stimulation of nitric oxide synthase. Diabetes 2000;49:1978-1985.
29. Sanyal AJ. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123:1705-1725.
30. Avogaro A, Toffolo G, Kiwanuka E, de Kreutzenberg SV, Tessari P, Cobelli C. L-Arginine-nitric oxide kinetics in normal and type 2 diabetic subjects a stable-labelled 15n arginine approach. Diabetes 2003;52:795-802.
31. Avogaro A, Fadini GP, Gallo A, Pagnin E, de Kreutzenberg S. Endothelial dysfunction in type 2 diabetes mellitus. Nutr Metab Cardiovas 2006;16:S39-S45.
32. Orellana-Gavaldà JM, Herrero L, Malandrino MI, Paneda A, Sol Rodríguez-Peña M, Petry H, et al. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation. Hepatology 2011;53:821-832.